Description

TAMILONG 20 TABLET is a highly effective anti-estrogen therapy formulated with Tamoxifen Citrate 20 mg, widely prescribed in the treatment of hormone receptor-positive breast cancer and as a preventive therapy in high-risk patients.

Tamoxifen acts as a Selective Estrogen Receptor Modulator (SERM). It blocks the effects of estrogen in breast tissue by binding to estrogen receptors, thereby slowing or stopping the growth of cancer cells that require estrogen to grow. It is also used to reduce the risk of developing breast cancer in women who are at a higher genetic or clinical risk.

• Treatment of estrogen receptor-positive (ER+) breast cancer

• Prevention of breast cancer in high-risk populations

• Adjuvant therapy in early and advanced breast cancer

• Management of ductal carcinoma in situ (DCIS)

• Fertility treatments (off-label use, under medical supervision)

• Effective first-line therapy for hormone-dependent breast cancer

• Reduces risk of recurrence and new tumor formation

• Also used in breast cancer prevention strategies

• Long-term safety profile with proven clinical efficacy

• Manufactured under stringent pharmaceutical standards

• Standard adult dose is 20 mg once daily, with or without food

• Duration of therapy depends on clinical condition and physician advice

• Follow-up and periodic monitoring recommended during treatment

• Not recommended during pregnancy or breastfeeding

• Regular gynecological and oncological follow-ups are advised

• May cause hot flashes, mood changes, or menstrual irregularities

• Use with caution in patients with a history of thrombosis or endometrial issues

TAMILONG 20 TABLET is manufactured in WHO-GMP, ISO, and FDA-approved facilities with rigorous quality control protocols. The product undergoes stringent analytical testing to ensure safety, stability, and therapeutic consistency.

BLUEPILL EXPRESS is a globally recognized third-party pharmaceutical manufacturer and exporter of high-quality medicines, including anti-cancer, cardiovascular, hormonal, and general health formulations. We serve markets across:

• Asia

• Africa

• CIS countries

• Europe

• Latin America

• Middle East